No AdComm Puts Sarepta On Path To Blockbuster Success With Duchenne Gene Therapy

Noises From US FDA Positive Ahead Of PDUFA

 
• By Andrew McConaghie
  
Sarepta building
Sarepta looks to be on the cusp of an historic approval for its Duchenne gene therapy, expected on 29 May. • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Business

More from Scrip